Conv. Plasma
Nigella Sativa
Nitric Oxide
Peg.. Lambda

Home   COVID-19 treatment studies for Vitamin D  COVID-19 treatment studies for Vitamin D  C19 studies: Vitamin D  Vitamin D   Select treatmentSelect treatmentTreatmentsTreatments
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta
Lactoferrin Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ Mortality 11% Improvement Relative Risk ICU admission 42% Severe case 40% di Filippo et al. Vitamin D for COVID-19 Sufficiency Favors vitamin D Favors control
Vitamin D levels associate with blood glucose and BMI in COVID-19 patients predicting disease severity
di Filippo et al, The Journal of Clinical Endocrinology & Metabolism, doi:10.1210/clinem/dgab599
di Filippo, Vitamin D levels associate with blood glucose and BMI in COVID-19 patients predicting disease severity, et al, The Journal of Clinical Endocrinology & Metabolism, doi:10.1210/clinem/dgab599
Aug 2021   Source   PDF  
  All Studies   Meta
Retrospective 88 patients in Italy, showing vitamin D deficiency associated with severe cases, blood glucose, and BMI.
risk of death, 10.7% lower, RR 0.89, p = 1.00, high D levels 5 of 28 (17.9%), low D levels 12 of 60 (20.0%), NNT 47, >20ng/mL.
risk of ICU admission, 41.6% lower, RR 0.58, p = 0.22, high D levels 6 of 28 (21.4%), low D levels 22 of 60 (36.7%), NNT 6.6, >20ng/mL.
risk of severe case, 39.6% lower, RR 0.60, p = 0.04, high D levels 11 of 28 (39.3%), low D levels 39 of 60 (65.0%), NNT 3.9, >20ng/mL.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
di Filippo et al., 12 Aug 2021, retrospective, Italy, peer-reviewed, 8 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperVitamin DAll
Abstract: Vitamin D levels associate with blood glucose and BMI in COVID-19 patients predicting disease severity MD, Massimo Locatelli2, MD, Patrizia Rovere Querini3, Professor, Stefano Frara1, MD, 1 us cr ip t Andrea Giustina1, Professor Institute of Endocrine and Metabolic Sciences, Vita-Salute San Raffaele University, IRCCS an San Raffaele Hospital, Milan, Italy Laboratory Medicine Service, IRCCS San Raffaele Hospital, Milan, Italy 3 Vita-Salute San Raffaele University and Division of Transplantation, Immunology and M 2 pt e d Infectious Diseases, IRCCS San Raffaele Hospital, Milan, Italy Correspondence: Prof. Andrea Giustina, Division of Endocrinology, IRCCS San Raffaele ce Hospital, via Olgettina 60, 20132 Milano, Italy; Ac Authors’ contributions: All authors contributed equally. Declarations: no funding supports. Disclosure Statement: The authors have nothing to disclose. The Work submitted for publication is original and has not been published in any language or format and has not been submitted elsewhere for print or electronic publication consideration. © The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: Luigi di Filippo1, MD, Agnese Allora1, MD, Mauro Doga1, MD, Anna Maria Formenti1, Abstract Context: High prevalence of Vitamin-D (VD) deficiency in COVID-19 patients was reported and inflammatory responses. Furthermore, clear associations between hypovitaminosis-D and us cr ip t fat body-mass excess and diabetes, factors associated with COVID-19 severity, have been widely recognized. Objective: The aim of this study was to evaluate in COVID-19 patients the relationship M an between VD levels and inflammatory response, BMI, blood glucose and disease severity. d Design: Patients admitted to San Raffaele-Hospital for COVID-19 were enrolled in this pt e study, excluding those with comorbidities and therapies influencing VD-metabolism. 25(OH)VD levels, plasma glucose levels, BMI and inflammatory parameters were evaluated Ac ce at admission. Results: A total of 88 patients were included. Median VD level was 16.3 ng/mL and VDdeficiency was found in 68.2% of patients. VD-deficiency was found more frequently in male patients and in those affected by severe COVID-19. Regression analyses showed a positive correlation between VD and PaO2/FiO2 ratio, and negative correlations between VD and plasma glucose, BMI, Neutrophil/Lymphocyte ratio, CRP and IL-6. 2 and hypothesized to increase COVID-19 severity likely due to its negative impact on immune Patients with both hypovitaminosis-D and diabetes mellitus, as well those with hypovitaminosis-D and overweight, were more frequently affected by a severe disease with worse inflammatory response and respiratory parameters, compared to those without or just one of these conditions. Conclusions: We showed, for the first-time, a strict association of VD levels with blood t glucose and BMI in COVID-19 patients. VD-deficiency might be a novel..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop